Cellectis SA (CLLS)
3.37
+0.14
(+4.33%)
USD |
NASDAQ |
Mar 25, 16:00
Cellectis Free Cash Flow : -43.68M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -98.65M |
| EDAP TMS SA | -- |
| Akari Therapeutics Plc | -9.678M |
| Biodexa Pharmaceuticals Plc | -14.30M |
| Autolus Therapeutics Plc | -306.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.47M |
| Cash from Investing (Quarterly) | 22.57M |
| Cash from Financing (Quarterly) | -4.029M |
| Free Cash Flow Per Share (Quarterly) | -0.1093 |
| Free Cash Flow to Equity (Quarterly) | -11.64M |
| Free Cash Flow to Firm (Quarterly) | -9.088M |
| Free Cash Flow Yield | -12.88% |